PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Casale, Thomas
TI  - CYT003-QbG10 Not Effective in Uncontrolled Allergic Asthma
DP  - 2014 Sep 01
TA  - MD Conference Express
PG  - 18--19
VI  - 14
IP  - 11
4099  - http://mdc.sagepub.com/content/14/11/18.short
4100  - http://mdc.sagepub.com/content/14/11/18.full
AB  - Treatment with the A-type CpG oligodeoxynucleotide CYT003-QbG10 did not improve asthma control or lung function in patients with allergic asthma not adequately controlled with inhaled corticosteroids. This article presents data from the Randomized, Placebo-Controlled, Phase IIb Dose-Finding Study of CYT003-QbG10, a TLR9-Agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma [NCT01673672; Casale T et al. Am J Respir Care Med 2014].